237385-15-8

Basic information

• Product Name: Methyl 4-broMo-5-Methylthiophene-2-carboxylate
• Synonyms: Methyl 4-broMo-5-Methylthiophene-2-carboxylate;4-BROMO-5-METHYL-2-THIOPHENECARBOXYLIC ACID METHYL ESTER
• CAS NO: 237385-15-8
• Molecular Formula: C₇H₇BrO₂S
• Molecular Weight: 235.09828
• Mol File: 237385-15-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 277.1±35.0 °C(Predicted)
• Appearance: /
• Density: 1.575±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Methyl 4-broMo-5-Methylthiophene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-broMo-5-Methylthiophene-2-carboxylate(237385-15-8)
• EPA Substance Registry System: Methyl 4-broMo-5-Methylthiophene-2-carboxylate(237385-15-8)

Safety Data

• Hazardous Substances Data: 237385-15-8(Hazardous Substances Data)

Usage

General Description

Methyl 4-bromo-5-methylthiophene-2-carboxylate is a chemical compound with the molecular formula C7H7BrO2S. It typically appears as a brownish liquid and is used primarily in the field of organic synthesis, particularly in the production of various pharmaceuticals and chemicals. Its properties include a high boiling point and relative stability, making it suitable for use in a variety of complex chemical reactions. As with any chemical, proper safety precautions, including handling and disposal, should be followed when using methyl 4-bromo-5-methylthiophene-2-carboxylate, due to its reactive nature and potential hazardous impact on human health and the environment.

Upstream product

• 19432-69-0 methyl 5-methylthiophene-2-carboxylate 
• 1918-79-2 2-methylthiophene-5-carboxylic acid 
• 1445-45-0 Trimethyl orthoacetate 
• 29421-99-6 4-bromo-5-methyl-thiophene-2-carboxylic acid 
• 67-56-1 methanol 
• 7311-63-9 5-bromothiophene-2-carboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 29421-73-6 3,5-dibromo-2-methylthiophene 

Downstream Products

• 1109284-49-2 methyl 5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate 
• 1047644-65-4 N-((1S)-2-amino-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-4-(1,4-dimethyl-1H-pyrazol-5-yl)-5-methyl-2-thiophenecarboxamide hydrochloride 
• 1047628-82-9 N-((1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-5-methyl-4-(1-methyl-4-propyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide 
• 1047646-05-8 N-[(1S)-2-amino-1-(cyclohexylmethyl)ethyl]-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-5-methyl-2-thiophenecarboxamide hydrochloride 
• 1047628-64-7 N-((1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-5-methyl-4-[1-methyl-4-(1-methylethyl)-1H-pyrazol-5-yl]-2-thiophenecarboxamide 
• 1047645-96-4 4-(1,4-dimethyl-1H-pyrazol-5-yl)-N-((1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-5-methyl-2-thiophenecarboxamide 
• 1047628-39-6 4-(4-bromo-1-methyl-1H-pyrazol-5-yl)-N-{(1S)-2-cyclohexyl-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]ethyl}-5-methyl-2-thiophenecarboxamide 
• 1047646-04-7 4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-N-{(1S)-2-cyclohexyl-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]ethyl}-5-methyl-2-thiophenecarboxamide 
• 1047646-06-9 N-{(1S)-2-cyclohexyl-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]ethyl}-5-methyl-4-(1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide 
• 1047627-39-3 N-((1S)-2-amino-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-5-methyl-4-(1-methyl-4-propyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide 
• 1047627-35-9 N-((1S)-2-amino-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-5-methyl-4-[1-methyl-4-(1-methylethyl)-1H-pyrazol-5-yl]-2-thiophenecarboxamide 
• 1047645-94-2 N-((1S)-2-amino-1-{[2-(trifluoromethyl)phenyl]methyl}ethyl)-4-(1,4-dimethyl-1H-pyrazol-5-yl)-5-methyl-2-thiophenecarboxamide 
• 1047627-27-9 N-[(1S)-2-amino-1-(cyclohexylmethyl)ethyl]-4-(4-bromo-1-methyl-1H-pyrazol-5-yl)-5-methyl-2-thiophenecarboxamide 
• 1047644-68-7 N-[(1S)-2-amino-1-(cyclohexylmethyl)ethyl]-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-5-methyl-2-thiophenecarboxamide 

Relevant articles and documents

PKB inhibitor

The invention provides a PKB inhibitor, particularly relates to a compound shown as a formula I or a pharmaceutically acceptable salt thereof. The invention further provides a preparation method of the compound.

In-Depth Assessment of the Palladium-Catalyzed Fluorination of Five-Membered Heteroaryl Bromides

A thorough investigation of the challenging Pd-catalyzed fluorination of five-membered heteroaryl bromides is presented. Crystallographic studies and density functional theory (DFT) calculations suggest that the challenging step of this transformation is

INHIBITORS OF AKT ACTIVITY

Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.